View More Guidelines in Anticoagulation Management >

Left Atrial Appendage Occlusion & Stroke, Hypertrophic Cardiomyopathy in Children, Anticoagulation & COVID-19

Jan 24, 2025   |  Kim A. Eagle, MD, MACC

Podcast

In this week’s View, Dr. Eagle looks at left atrial appendage occlusion for stroke prevention in patients with AFib. He then discusses a new treatment for severe hypertrophic cardiomyopathy in children. Finally, Dr. Eagle explores anticoagulation...

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, COVID-19 Hub, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Heart Transplant, Interventions and Structural Heart Disease, Acute Coronary Syndromes, Valvular Heart Disease

Keywords: Stroke, Atrial Fibrillation, Cardiac Surgical Procedures, Heart Transplantation, Mitogen-Activated Protein Kinase Kinases, Cardiomyopathy, Hypertrophic, COVID-19, Anticoagulants, World Health Organization

Rivaroxaban Beyond 6 Weeks: Enhancing Outcomes in Isolated Distal Deep Vein Thrombosis

Jan 14, 2025   |  Abdelrhman Abumoawad, MD; Yulanka Castro Dominguez, MD, FACC; Christopher Jennings Regan, MD, FACC

Expert Analysis

The optimal management of isolated, distal deep vein thrombosis (DVT) remains unclear. Data from recent studies suggest that certain patients may benefit from anticoagulation...

Clinical Topics: Anticoagulation Management, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Anticoagulation Management and Venothromboembolism

Keywords: Rivaroxaban, Venous Thrombosis, Anticoagulation Management, Anticoagulants, Venous Thromboembolism

Therapeutic- vs. Prophylactic-Dose Anticoagulation Reduces Mortality in Patients Hospitalized For COVID-19

Jan 10, 2025

ACC News Story

Therapeutic- compared with prophylactic-dose anticoagulation was associated with reduced 28-day mortality in patients hospitalized for COVID-19, according to a prospective meta-analysis from the World Health Organization (WHO) Rapid Evidence...

Clinical Topics: Anticoagulation Management, COVID-19 Hub

Keywords: COVID-19, Anticoagulants, World Health Organization

What Cardiologists Should Know About Congenital Heart Disease, Cardiac Arrest and Death in Athletes, Arrhythmia After Stroke

Dec 18, 2024   |  Kim A. Eagle, MD, MACC

Podcast

In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational athletes.

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, Prevention, Sports and Exercise Cardiology, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, Sports and Exercise and Congenital Heart Disease and Pediatric Cardiology, Cardiovascular Care Team, Vascular Medicine

Keywords: EaglesEyeView, Heart Defects, Congenital, Patient Care, Patient Care Team, Athletes, Death, Sudden, Heart Arrest, Primary Prevention, Secondary Prevention, Anticoagulants, Atrial Fibrillation, Ischemic Stroke

View More Articles and Stories in Anticoagulation Management >

Results 1-6 of 2,813

View More JACC Journals in Anticoagulation Management >

View More Educational Activities in Anticoagulation Management >

View More Meetings in Anticoagulation Management >

View More Images and Slides in Anticoagulation Management >

Date

View More Anticoagulation Management Resources >